3.26.1 html 1194 538 1 true 221 0 false 26 false false R1.htm 0000001 - Document - Cover Sheet http://www.innate-pharma.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.innate-pharma.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 9952151 - Statement - Consolidated Statements of Financial Position Sheet http://www.innate-pharma.com/role/ConsolidatedStatementsofFinancialPosition Consolidated Statements of Financial Position Statements 3 false false R4.htm 9952152 - Statement - Consolidated Statements of Income (Loss) Sheet http://www.innate-pharma.com/role/ConsolidatedStatementsofIncomeLoss Consolidated Statements of Income (Loss) Statements 4 false false R5.htm 9952153 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.innate-pharma.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 9952154 - Statement - Consolidated Statement of Cash Flows Sheet http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlows Consolidated Statement of Cash Flows Statements 6 false false R7.htm 9952155 - Statement - Consolidated Statement of Cash Flows - Parenthetical Sheet http://www.innate-pharma.com/role/ConsolidatedStatementofCashFlowsParenthetical Consolidated Statement of Cash Flows - Parenthetical Statements 7 false false R8.htm 9952156 - Statement - Consolidated Statement of Changes in Shareholders' Equity Sheet http://www.innate-pharma.com/role/ConsolidatedStatementofChangesinShareholdersEquity Consolidated Statement of Changes in Shareholders' Equity Statements 8 false false R9.htm 9952157 - Disclosure - The company Sheet http://www.innate-pharma.com/role/Thecompany The company Notes 9 false false R10.htm 9952158 - Disclosure - Accounting policies and statement of compliance Sheet http://www.innate-pharma.com/role/Accountingpoliciesandstatementofcompliance Accounting policies and statement of compliance Notes 10 false false R11.htm 9952159 - Disclosure - Management of financial risks and fair value Sheet http://www.innate-pharma.com/role/Managementoffinancialrisksandfairvalue Management of financial risks and fair value Notes 11 false false R12.htm 9952160 - Disclosure - Cash, cash equivalents and financial assets Sheet http://www.innate-pharma.com/role/Cashcashequivalentsandfinancialassets Cash, cash equivalents and financial assets Notes 12 false false R13.htm 9952161 - Disclosure - Trade receivables and others Sheet http://www.innate-pharma.com/role/Tradereceivablesandothers Trade receivables and others Notes 13 false false R14.htm 9952162 - Disclosure - Intangible assets Sheet http://www.innate-pharma.com/role/Intangibleassets Intangible assets Notes 14 false false R15.htm 9952163 - Disclosure - Property and equipment Sheet http://www.innate-pharma.com/role/Propertyandequipment Property and equipment Notes 15 false false R16.htm 9952164 - Disclosure - Trade payables and others Sheet http://www.innate-pharma.com/role/Tradepayablesandothers Trade payables and others Notes 16 false false R17.htm 9952165 - Disclosure - Financial liabilities Sheet http://www.innate-pharma.com/role/Financialliabilities Financial liabilities Notes 17 false false R18.htm 9952166 - Disclosure - Employee benefits Sheet http://www.innate-pharma.com/role/Employeebenefits Employee benefits Notes 18 false false R19.htm 9952167 - Disclosure - Share capital and share based payments Sheet http://www.innate-pharma.com/role/Sharecapitalandsharebasedpayments Share capital and share based payments Notes 19 false false R20.htm 9952168 - Disclosure - Financial instruments recognized in the statement of financial position and related effect on the income statement Sheet http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement Financial instruments recognized in the statement of financial position and related effect on the income statement Notes 20 false false R21.htm 9952169 - Disclosure - Revenue and government financing for research expenditures Sheet http://www.innate-pharma.com/role/Revenueandgovernmentfinancingforresearchexpenditures Revenue and government financing for research expenditures Notes 21 false false R22.htm 9952170 - Disclosure - Operating expenses Sheet http://www.innate-pharma.com/role/Operatingexpenses Operating expenses Notes 22 false false R23.htm 9952171 - Disclosure - Net financial income (loss) Sheet http://www.innate-pharma.com/role/Netfinancialincomeloss Net financial income (loss) Notes 23 false false R24.htm 9952172 - Disclosure - Income Tax Sheet http://www.innate-pharma.com/role/IncomeTax Income Tax Notes 24 false false R25.htm 9952173 - Disclosure - Commitments, contingencies and litigations Sheet http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigations Commitments, contingencies and litigations Notes 25 false false R26.htm 9952174 - Disclosure - Related party transactions Sheet http://www.innate-pharma.com/role/Relatedpartytransactions Related party transactions Notes 26 false false R27.htm 9952175 - Disclosure - Income (loss) per share Sheet http://www.innate-pharma.com/role/Incomelosspershare Income (loss) per share Notes 27 false false R28.htm 9952176 - Disclosure - Events after the reporting date Sheet http://www.innate-pharma.com/role/Eventsafterthereportingdate Events after the reporting date Notes 28 false false R29.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 29 false false R30.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 30 false false R31.htm 9955511 - Disclosure - Accounting policies and statement of compliance (Policies) Sheet http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcompliancePolicies Accounting policies and statement of compliance (Policies) Policies http://www.innate-pharma.com/role/Accountingpoliciesandstatementofcompliance 31 false false R32.htm 9955512 - Disclosure - The company (Tables) Sheet http://www.innate-pharma.com/role/ThecompanyTables The company (Tables) Tables http://www.innate-pharma.com/role/Thecompany 32 false false R33.htm 9955513 - Disclosure - Accounting policies and statement of compliance (Tables) Sheet http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceTables Accounting policies and statement of compliance (Tables) Tables http://www.innate-pharma.com/role/Accountingpoliciesandstatementofcompliance 33 false false R34.htm 9955514 - Disclosure - Cash, cash equivalents and financial assets (Tables) Sheet http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsTables Cash, cash equivalents and financial assets (Tables) Tables http://www.innate-pharma.com/role/Cashcashequivalentsandfinancialassets 34 false false R35.htm 9955515 - Disclosure - Trade receivables and others (Tables) Sheet http://www.innate-pharma.com/role/TradereceivablesandothersTables Trade receivables and others (Tables) Tables http://www.innate-pharma.com/role/Tradereceivablesandothers 35 false false R36.htm 9955516 - Disclosure - Intangible assets (Tables) Sheet http://www.innate-pharma.com/role/IntangibleassetsTables Intangible assets (Tables) Tables http://www.innate-pharma.com/role/Intangibleassets 36 false false R37.htm 9955517 - Disclosure - Property and equipment (Tables) Sheet http://www.innate-pharma.com/role/PropertyandequipmentTables Property and equipment (Tables) Tables http://www.innate-pharma.com/role/Propertyandequipment 37 false false R38.htm 9955518 - Disclosure - Trade payables and others (Tables) Sheet http://www.innate-pharma.com/role/TradepayablesandothersTables Trade payables and others (Tables) Tables http://www.innate-pharma.com/role/Tradepayablesandothers 38 false false R39.htm 9955519 - Disclosure - Financial liabilities (Tables) Sheet http://www.innate-pharma.com/role/FinancialliabilitiesTables Financial liabilities (Tables) Tables http://www.innate-pharma.com/role/Financialliabilities 39 false false R40.htm 9955520 - Disclosure - Employee benefits (Tables) Sheet http://www.innate-pharma.com/role/EmployeebenefitsTables Employee benefits (Tables) Tables http://www.innate-pharma.com/role/Employeebenefits 40 false false R41.htm 9955521 - Disclosure - Share capital and share based payments (Tables) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsTables Share capital and share based payments (Tables) Tables http://www.innate-pharma.com/role/Sharecapitalandsharebasedpayments 41 false false R42.htm 9955522 - Disclosure - Financial instruments recognized in the statement of financial position and related effect on the income statement (Tables) Sheet http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables Financial instruments recognized in the statement of financial position and related effect on the income statement (Tables) Tables http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement 42 false false R43.htm 9955523 - Disclosure - Revenue and government financing for research expenditures (Tables) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresTables Revenue and government financing for research expenditures (Tables) Tables http://www.innate-pharma.com/role/Revenueandgovernmentfinancingforresearchexpenditures 43 false false R44.htm 9955524 - Disclosure - Operating expenses (Tables) Sheet http://www.innate-pharma.com/role/OperatingexpensesTables Operating expenses (Tables) Tables http://www.innate-pharma.com/role/Operatingexpenses 44 false false R45.htm 9955525 - Disclosure - Net financial income (loss) (Tables) Sheet http://www.innate-pharma.com/role/NetfinancialincomelossTables Net financial income (loss) (Tables) Tables http://www.innate-pharma.com/role/Netfinancialincomeloss 45 false false R46.htm 9955526 - Disclosure - Income Tax (Tables) Sheet http://www.innate-pharma.com/role/IncomeTaxTables Income Tax (Tables) Tables http://www.innate-pharma.com/role/IncomeTax 46 false false R47.htm 9955527 - Disclosure - Related party transactions (Tables) Sheet http://www.innate-pharma.com/role/RelatedpartytransactionsTables Related party transactions (Tables) Tables http://www.innate-pharma.com/role/Relatedpartytransactions 47 false false R48.htm 9955528 - Disclosure - Income (loss) per share (Tables) Sheet http://www.innate-pharma.com/role/IncomelosspershareTables Income (loss) per share (Tables) Tables http://www.innate-pharma.com/role/IncomeTax 48 false false R49.htm 9955529 - Disclosure - The company - Additional Information (Details) Sheet http://www.innate-pharma.com/role/ThecompanyAdditionalInformationDetails The company - Additional Information (Details) Details 49 false false R50.htm 9955530 - Disclosure - The company - 2014 Novo Nordisk A/S monalizumab agreement (Details) Sheet http://www.innate-pharma.com/role/Thecompany2014NovoNordiskASmonalizumabagreementDetails The company - 2014 Novo Nordisk A/S monalizumab agreement (Details) Details 50 false false R51.htm 9955531 - Disclosure - The company - 2015 AstraZeneca monalizumab agreements (Details) Sheet http://www.innate-pharma.com/role/Thecompany2015AstraZenecamonalizumabagreementsDetails The company - 2015 AstraZeneca monalizumab agreements (Details) Details 51 false false R52.htm 9955532 - Disclosure - The company - Agreement related to IPH5201 with AstraZeneca (Details) Sheet http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoIPH5201withAstraZenecaDetails The company - Agreement related to IPH5201 with AstraZeneca (Details) Details 52 false false R53.htm 9955533 - Disclosure - The company - Agreement related to additional preclinical molecules with AstraZeneca (Details) Sheet http://www.innate-pharma.com/role/ThecompanyAgreementrelatedtoadditionalpreclinicalmoleculeswithAstraZenecaDetails The company - Agreement related to additional preclinical molecules with AstraZeneca (Details) Details 53 false false R54.htm 9955534 - Disclosure - The company - Agreements related to avdoralimab with Novo Nordisk and with AstraZeneca (Details) Sheet http://www.innate-pharma.com/role/ThecompanyAgreementsrelatedtoavdoralimabwithNovoNordiskandwithAstraZenecaDetails The company - Agreements related to avdoralimab with Novo Nordisk and with AstraZeneca (Details) Details 54 false false R55.htm 9955535 - Disclosure - The company - Collaboration and license agreements concluded with Sanofi for the development of "NK Cell engages" in oncology (Details) Sheet http://www.innate-pharma.com/role/ThecompanyCollaborationandlicenseagreementsconcludedwithSanofiforthedevelopmentofNKCellengagesinoncologyDetails The company - Collaboration and license agreements concluded with Sanofi for the development of "NK Cell engages" in oncology (Details) Details 55 false false R56.htm 9955536 - Disclosure - The company - Key events (Details) Sheet http://www.innate-pharma.com/role/ThecompanyKeyeventsDetails The company - Key events (Details) Details 56 false false R57.htm 9955537 - Disclosure - The Company - Summary of the company's shareholding information (Details) Sheet http://www.innate-pharma.com/role/TheCompanySummaryofthecompanysshareholdinginformationDetails The Company - Summary of the company's shareholding information (Details) Details 57 false false R58.htm 9955538 - Disclosure - Accounting policies and statement of compliance - Additional Information (Details) Sheet http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceAdditionalInformationDetails Accounting policies and statement of compliance - Additional Information (Details) Details 58 false false R59.htm 9955539 - Disclosure - Accounting policies and statement of compliance - Disclosure of Effect of Changes in Foreign Exchange Rates (Details) Sheet http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofEffectofChangesinForeignExchangeRatesDetails Accounting policies and statement of compliance - Disclosure of Effect of Changes in Foreign Exchange Rates (Details) Details 59 false false R60.htm 9955540 - Disclosure - Accounting policies and statement of compliance - Disclosure of Depreciation Periods (Details) Sheet http://www.innate-pharma.com/role/AccountingpoliciesandstatementofcomplianceDisclosureofDepreciationPeriodsDetails Accounting policies and statement of compliance - Disclosure of Depreciation Periods (Details) Details 60 false false R61.htm 9955541 - Disclosure - Management of financial risks and fair value (Details) Sheet http://www.innate-pharma.com/role/ManagementoffinancialrisksandfairvalueDetails Management of financial risks and fair value (Details) Details http://www.innate-pharma.com/role/Managementoffinancialrisksandfairvalue 61 false false R62.htm 9955542 - Disclosure - Cash, cash equivalents and financial assets - Disclosure of Cash, Cash Equivalents and Financial Assets (Details) Sheet http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofCashCashEquivalentsandFinancialAssetsDetails Cash, cash equivalents and financial assets - Disclosure of Cash, Cash Equivalents and Financial Assets (Details) Details 62 false false R63.htm 9955543 - Disclosure - Cash, cash equivalents and financial assets - Additional Information (Details) Sheet http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsAdditionalInformationDetails Cash, cash equivalents and financial assets - Additional Information (Details) Details 63 false false R64.htm 9955544 - Disclosure - Cash, cash equivalents and financial assets - Disclosure of Reconciliation of Changes in Loss Allowance and Explanation of Changes in Gross Carrying Amount for Financial Instruments (Details) Sheet http://www.innate-pharma.com/role/CashcashequivalentsandfinancialassetsDisclosureofReconciliationofChangesinLossAllowanceandExplanationofChangesinGrossCarryingAmountforFinancialInstrumentsDetails Cash, cash equivalents and financial assets - Disclosure of Reconciliation of Changes in Loss Allowance and Explanation of Changes in Gross Carrying Amount for Financial Instruments (Details) Details 64 false false R65.htm 9955545 - Disclosure - Trade receivables and others (Details) Sheet http://www.innate-pharma.com/role/TradereceivablesandothersDetails Trade receivables and others (Details) Details http://www.innate-pharma.com/role/TradereceivablesandothersTables 65 false false R66.htm 9955546 - Disclosure - Intangible assets - Disclosure of Detailed Information about Intangible Assets (Details) Sheet http://www.innate-pharma.com/role/IntangibleassetsDisclosureofDetailedInformationaboutIntangibleAssetsDetails Intangible assets - Disclosure of Detailed Information about Intangible Assets (Details) Details 66 false false R67.htm 9955547 - Disclosure - Intangible assets - Additional Information (Details) Sheet http://www.innate-pharma.com/role/IntangibleassetsAdditionalInformationDetails Intangible assets - Additional Information (Details) Details 67 false false R68.htm 9955548 - Disclosure - Property and equipment (Details) Sheet http://www.innate-pharma.com/role/PropertyandequipmentDetails Property and equipment (Details) Details http://www.innate-pharma.com/role/PropertyandequipmentTables 68 false false R69.htm 9955549 - Disclosure - Trade payables and others (Details) Sheet http://www.innate-pharma.com/role/TradepayablesandothersDetails Trade payables and others (Details) Details http://www.innate-pharma.com/role/TradepayablesandothersTables 69 false false R70.htm 9955550 - Disclosure - Financial liabilities - Disclosure of Financial Liabilities Per Maturity (Details) Sheet http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofFinancialLiabilitiesPerMaturityDetails Financial liabilities - Disclosure of Financial Liabilities Per Maturity (Details) Details 70 false false R71.htm 9955551 - Disclosure - Financial liabilities - Additional Information (Details) Sheet http://www.innate-pharma.com/role/FinancialliabilitiesAdditionalInformationDetails Financial liabilities - Additional Information (Details) Details 71 false false R72.htm 9955552 - Disclosure - Financial liabilities - Disclosure of Schedule for the Contractual Flows of Financial Liabilities (Details) Sheet http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofSchedulefortheContractualFlowsofFinancialLiabilitiesDetails Financial liabilities - Disclosure of Schedule for the Contractual Flows of Financial Liabilities (Details) Details 72 false false R73.htm 9955553 - Disclosure - Financial liabilities - Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities (Details) Sheet http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofMaturityAnalysisforNonDerivativeFinancialLiabilitiesDetails Financial liabilities - Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities (Details) Details 73 false false R74.htm 9955554 - Disclosure - Employee benefits - Disclosure of defined benefit plans (Details) Sheet http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofdefinedbenefitplansDetails Employee benefits - Disclosure of defined benefit plans (Details) Details 74 false false R75.htm 9955555 - Disclosure - Employee benefits - Additional Information (Details) Sheet http://www.innate-pharma.com/role/EmployeebenefitsAdditionalInformationDetails Employee benefits - Additional Information (Details) Details 75 false false R76.htm 9955556 - Disclosure - Employee benefits - Disclosure of Actuarial Assumptions for Defined Benefit Plans (Details) Sheet http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofActuarialAssumptionsforDefinedBenefitPlansDetails Employee benefits - Disclosure of Actuarial Assumptions for Defined Benefit Plans (Details) Details 76 false false R77.htm 9955557 - Disclosure - Employee benefits - Disclosure of Net Defined Benefit Liability (Asset) (Details) Sheet http://www.innate-pharma.com/role/EmployeebenefitsDisclosureofNetDefinedBenefitLiabilityAssetDetails Employee benefits - Disclosure of Net Defined Benefit Liability (Asset) (Details) Details 77 false false R78.htm 9955558 - Disclosure - Share capital and share based payments - Additional Information (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsAdditionalInformationDetails Share capital and share based payments - Additional Information (Details) Details 78 false false R79.htm 9955559 - Disclosure - Share capital and share based payments - Disclosure of Changes in Share Capital (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinShareCapitalDetails Share capital and share based payments - Disclosure of Changes in Share Capital (Details) Details 79 false false R80.htm 9955560 - Disclosure - Share capital and share based payments - Disclosure of Number and Weighted Average Exercise Prices of Other Equity Instruments (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofNumberandWeightedAverageExercisePricesofOtherEquityInstrumentsDetails Share capital and share based payments - Disclosure of Number and Weighted Average Exercise Prices of Other Equity Instruments (Details) Details 80 false false R81.htm 9955561 - Disclosure - Share capital and share based payments - Disclosure of Terms and Conditions of Other Equity Instruments (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofTermsandConditionsofOtherEquityInstrumentsDetails Share capital and share based payments - Disclosure of Terms and Conditions of Other Equity Instruments (Details) Details 81 false false R82.htm 9955562 - Disclosure - Share capital and share based payments - Disclosure of Changes in Number of Other Equity Instruments Outstanding (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofChangesinNumberofOtherEquityInstrumentsOutstandingDetails Share capital and share based payments - Disclosure of Changes in Number of Other Equity Instruments Outstanding (Details) Details 82 false false R83.htm 9955563 - Disclosure - Share capital and share based payments - Disclosure of Closing Balance of Share-Based Payment Arrangements (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofClosingBalanceofShareBasedPaymentArrangementsDetails Share capital and share based payments - Disclosure of Closing Balance of Share-Based Payment Arrangements (Details) Details 83 false false R84.htm 9955564 - Disclosure - Share capital and share based payments - Disclosure of Breakdown of Expenses per Financial Year (Details) Sheet http://www.innate-pharma.com/role/SharecapitalandsharebasedpaymentsDisclosureofBreakdownofExpensesperFinancialYearDetails Share capital and share based payments - Disclosure of Breakdown of Expenses per Financial Year (Details) Details 84 false false R85.htm 9955565 - Disclosure - Financial instruments recognized in the statement of financial position and related effect on the income statement (Details) Sheet http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDetails Financial instruments recognized in the statement of financial position and related effect on the income statement (Details) Details http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables 85 false false R86.htm 9955566 - Disclosure - Revenue and government financing for research expenditures - Additional Information (Details) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresAdditionalInformationDetails Revenue and government financing for research expenditures - Additional Information (Details) Details 86 false false R87.htm 9955567 - Disclosure - Revenue and government financing for research expenditures - Disclosure of Revenue from Collaboration and Licensing Agreements (Details) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofRevenuefromCollaborationandLicensingAgreementsDetails Revenue and government financing for research expenditures - Disclosure of Revenue from Collaboration and Licensing Agreements (Details) Details 87 false false R88.htm 9955568 - Disclosure - Revenue and government financing for research expenditures - Disclosure of Changes in Deferred Revenue and Collaboration Liabilities (Details) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofChangesinDeferredRevenueandCollaborationLiabilitiesDetails Revenue and government financing for research expenditures - Disclosure of Changes in Deferred Revenue and Collaboration Liabilities (Details) Details 88 false false R89.htm 9955569 - Disclosure - Revenue and government financing for research expenditures - Disclosure of Variance of Deferred Revenue (Details) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofVarianceofDeferredRevenueDetails Revenue and government financing for research expenditures - Disclosure of Variance of Deferred Revenue (Details) Details 89 false false R90.htm 9955570 - Disclosure - Revenue and government financing for research expenditures - Disclosure of Government Financing for Research Expenditures (Details) Sheet http://www.innate-pharma.com/role/RevenueandgovernmentfinancingforresearchexpendituresDisclosureofGovernmentFinancingforResearchExpendituresDetails Revenue and government financing for research expenditures - Disclosure of Government Financing for Research Expenditures (Details) Details 90 false false R91.htm 9955571 - Disclosure - Operating expenses - Disclosure of Expenses by Nature (Details) Sheet http://www.innate-pharma.com/role/OperatingexpensesDisclosureofExpensesbyNatureDetails Operating expenses - Disclosure of Expenses by Nature (Details) Details 91 false false R92.htm 9955572 - Disclosure - Operating expenses - Disclosure of Audit and Non-Audit Fees (Details) Sheet http://www.innate-pharma.com/role/OperatingexpensesDisclosureofAuditandNonAuditFeesDetails Operating expenses - Disclosure of Audit and Non-Audit Fees (Details) Details 92 false false R93.htm 9955573 - Disclosure - Operating expenses - Additional Information (Details) Sheet http://www.innate-pharma.com/role/OperatingexpensesAdditionalInformationDetails Operating expenses - Additional Information (Details) Details 93 false false R94.htm 9955574 - Disclosure - Net financial income (loss) (Details) Sheet http://www.innate-pharma.com/role/NetfinancialincomelossDetails Net financial income (loss) (Details) Details http://www.innate-pharma.com/role/NetfinancialincomelossTables 94 false false R95.htm 9955575 - Disclosure - Income Tax - Disclosure of Deferred Assets and Liabilities (Details) Sheet http://www.innate-pharma.com/role/IncomeTaxDisclosureofDeferredAssetsandLiabilitiesDetails Income Tax - Disclosure of Deferred Assets and Liabilities (Details) Details 95 false false R96.htm 9955576 - Disclosure - Income Tax - Additional Information (Details) Sheet http://www.innate-pharma.com/role/IncomeTaxAdditionalInformationDetails Income Tax - Additional Information (Details) Details 96 false false R97.htm 9955577 - Disclosure - Income Tax - Disclosure of Tax Rate Reconciliation (Details) Sheet http://www.innate-pharma.com/role/IncomeTaxDisclosureofTaxRateReconciliationDetails Income Tax - Disclosure of Tax Rate Reconciliation (Details) Details 97 false false R98.htm 9955578 - Disclosure - Commitments, contingencies and litigations (Details) Sheet http://www.innate-pharma.com/role/CommitmentscontingenciesandlitigationsDetails Commitments, contingencies and litigations (Details) Details http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigations 98 false false R99.htm 9955579 - Disclosure - Related party transactions - Disclosure of Key Management Personnel Compensation (Details) Sheet http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofKeyManagementPersonnelCompensationDetails Related party transactions - Disclosure of Key Management Personnel Compensation (Details) Details 99 false false R100.htm 9955580 - Disclosure - Related party transactions - Additional Information (Details) Sheet http://www.innate-pharma.com/role/RelatedpartytransactionsAdditionalInformationDetails Related party transactions - Additional Information (Details) Details 100 false false R101.htm 9955581 - Disclosure - Related party transactions - Disclosure of Transactions Between Related Parties (Details) Sheet http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofTransactionsBetweenRelatedPartiesDetails Related party transactions - Disclosure of Transactions Between Related Parties (Details) Details 101 false false R102.htm 9955582 - Disclosure - Income (loss) per share - Summary of Income (Loss) per Share (Details) Sheet http://www.innate-pharma.com/role/IncomelosspershareSummaryofIncomeLossperShareDetails Income (loss) per share - Summary of Income (Loss) per Share (Details) Details http://www.innate-pharma.com/role/IncomeTaxTables 102 false false R103.htm 9955583 - Disclosure - Income (loss) per share - Additional Information (Details) Sheet http://www.innate-pharma.com/role/IncomelosspershareAdditionalInformationDetails Income (loss) per share - Additional Information (Details) Details http://www.innate-pharma.com/role/IncomeTaxTables 103 false false All Reports Book All Reports inpha-20251231.htm inpha-20251231.xsd inpha-20251231_cal.xml inpha-20251231_def.xml inpha-20251231_lab.xml inpha-20251231_pre.xml inpha-20251231_g1.jpg inpha-20251231_g10.jpg inpha-20251231_g11.jpg inpha-20251231_g12.jpg inpha-20251231_g13.jpg inpha-20251231_g14.jpg inpha-20251231_g15.jpg inpha-20251231_g2.jpg inpha-20251231_g3.jpg inpha-20251231_g4.jpg inpha-20251231_g5.jpg inpha-20251231_g6.jpg inpha-20251231_g7.jpg inpha-20251231_g8.jpg inpha-20251231_g9.jpg http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full true true